Jpmorgan Chase & CO Rapid Micro Biosystems, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPID
# of Institutions
23Shares Held
18.6MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA8.43MShares$9.11 Million1.14% of portfolio
-
Kennedy Lewis Management LP New York, NY4.94MShares$5.34 Million20.16% of portfolio
-
Glenview Capital Management, LLC New York, NY1.2MShares$1.3 Million0.02% of portfolio
-
Abg Wtt Global Life Science Capital Partners Gp LTD Hong Kong, F41.04MShares$1.12 Million64.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA728KShares$786,7620.0% of portfolio
About RAPID MICRO BIOSYSTEMS, INC.
- Ticker RPID
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,389,100
- Market Cap $39.3M
- Description
- Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumab...